SARS-CoV-2 evolution during persistent infection in a CAR-T recipient shows an escape to both sotrovimab and T-cell responses
J Clin Virol Plus
.
2023 Jun;3(2):100149.
doi: 10.1016/j.jcvp.2023.100149.
Epub 2023 Apr 21.
Authors
Paola Mazzetti
1
,
Pietro Giorgio Spezia
2
,
Anna-Lisa Capria
1
,
Giulia Freer
2
,
Maria Sidoti
1
2
,
Silvia Costarelli
3
,
Alice Cara
1
,
Alfredo Rosellini
1
,
Susi Frateschi
1
,
Giovanna Moscato
1
,
Iacopo Franconi
1
,
Michele Curcio
4
,
Maria Linda Vatteroni
1
,
Michele Lai
2
,
Paola Quaranta
2
,
Daniele Focosi
5
,
Spartaco Sani
3
,
Mauro Pistello
1
2
Affiliations
1
Virology Unit, Pisa University Hospital, Pisa, Italy.
2
Retrovirus Center and Virology Section, Department Translational Research, University of Pisa, Pisa, Italy.
3
Infectious Diseases Unit, Leghorn Hospital, Azienda USL Toscana Nord-Ovest, Italy.
4
Immunogenetic Unit, Pisa University Hospital, Pisa, Italy.
5
North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.
PMID:
37128202
PMCID:
PMC10121064
DOI:
10.1016/j.jcvp.2023.100149
No abstract available